Try our mobile app
Screener
Company
Price and
change
Revenue Growth
last / hist
EV /
LTM
EBITDA
(p75)
EV/
Sales
EBITDA LTM
/ Revenue
FCF LTM
/ Revenue
Next GAAP report
Year div-d yield
FCF Yield LTM
200.0%  /
82.6%
>200x
93.4x
5.5x
-10.9%
58.1%
..
1.3%
10.6% 
-42.9%  /
79.3%
1.2x
5.4x
1.5x
18.2%
13.6%
..
4.2%
9.4% 
-58.3%  /
77.2%
2.3x
2.1x
2.1x
117.9%
492.9%
..
15.4%
233.9% 
-7.7%  /
65.3%
>200x
>200x
4.1x
-11263.3%
1150.0%
..
20.6%
282.8% 
-10.0%  /
61.4%
41.5x
32.5x
8.7x
18.4%
-5.1%
..
2.1%
-0.6% 
-38.9%  /
57.4%
3x
3x
1.8x
103.9%
155.1%
..
14.0%
86.1% 
-53.6%  /
54.0%
41.9x
25.2x
8.8x
28.6%
-281.0%
..
2.3%
-32.1% 
-97.2%  /
53.7%
0.1x
0.9x
4x
377.3%
19097.7%
..
0.0%
4 774.4% 
-89.5%  /
52.8%
14.7x
10.4x
11.1x
95.3%
12.5%
..
0.6%
1.1% 
-33.6%  /
49.0%
12.1x
8.1x
3.2x
37.7%
-110.8%
..
3.0%
-34.2% 
12.9%  /
43.9%
2.1x
2.1x
0x
1.6%
0.0%
..
0.0%
--- 
-6.7%  /
42.2%
22.8x
11.9x
8.5x
80.4%
347.8%
2025-05-12
11.1%
40.9% 
100.0%  /
41.7%
>200x
36x
0.2x
-166.7%
0.0%
..
0.0%
--- 
-64.4%  /
38.5%
24.2x
15.7x
10.8x
65.3%
-70.6%
..
7.3%
-6.6% 
-83.0%  /
37.9%
30.7x
26.8x
11.1x
38.2%
-69.5%
..
2.7%
-6.3% 
-75.0%  /
35.5%
17.6x
13.1x
13.1x
100.0%
45.5%
2025-05-15
10.4%
3.5% 
-48.6%  /
34.9%
20x
9.2x
8.3x
96.3%
161.5%
..
6.2%
19.5% 
200.0%  /
27.8%
2.2x
2.2x
0.5x
24.1%
0.0%
..
8.7%
--- 
-60.0%  /
27.2%
17.7x
10.4x
8.1x
90.1%
-722.5%
2025-05-14
12.2%
-89.1% 
38.0%  /
26.4%
52.1x
41.7x
18x
35.2%
77.0%
2025-05-22
1.1%
4.3% 
34.9%  /
25.2%
50.5x
76.1x
4.6x
6.4%
0.0%
2025-05-13
1.2%
--- 
-42.9%  /
24.3%
15.5x
13.6x
15.5x
117.6%
71.6%
..
9.0%
4.6% 
-63.6%  /
24.3%
>200x
>200x
6.8x
-57.5%
570.0%
..
2.7%
83.8% 
-3.6%  /
19.3%
>200x
>200x
4x
-17.9%
0.0%
2025-05-09
4.5%
--- 
8.2%  /
17.0%
18.4x
19.5x
3.6x
19.4%
0.0%
..
0.0%
--- 
-63.0%  /
15.3%
>200x
>200x
5x
-42251.0%
-386.7%
..
11.3%
-77.5% 
200.0%  /
14.1%
6.8x
14.6x
2.1x
30.4%
0.0%
..
3.9%
--- 
200.0%  /
13.9%
>200x
9.9x
2x
17.7%
883.2%
..
3.0%
446.7% 
-15.6%  /
9.6%
5x
5.1x
0.3x
5.4%
0.0%
..
2.8%
--- 
11.6%  /
8.5%
3.1x
3.2x
0.8x
24.6%
0.0%
..
8.1%
--- 
-18.6%  /
7.7%
6.9x
9.2x
2.9x
37.0%
40.9%
..
4.2%
13.9% 
-22.7%  /
7.2%
8.7x
11.8x
14.3x
109.6%
-395.6%
..
8.4%
-27.7% 
21.6%  /
6.5%
5.6x
7.2x
1.5x
25.9%
0.0%
2025-05-15
21.7%
--- 
-75.0%  /
5.2%
33.9x
16.6x
7.4x
43.8%
-273.4%
2025-05-13
10.5%
-36.8% 
14.8%  /
4.1%
26.5x
21x
5.3x
20.0%
0.0%
..
1.1%
--- 
8.6%  /
3.0%
8.3x
6x
2.9x
44.4%
-16.7%
..
0.0%
-5.8% 
20.0%  /
2.8%
11.9x
41.4x
3.6x
8.7%
0.0%
2025-05-15
29.3%
--- 
8.9%  /
2.3%
>200x
>200x
0.8x
-2.5%
0.0%
..
0.0%
--- 
13.6%  /
2.3%
7.9x
7.8x
7.9x
98.6%
688.9%
..
8.9%
87.0% 
7.7%  /
1.7%
23.2x
22.1x
7.8x
33.4%
0.0%
..
2.1%
--- 
13.1%  /
0.7%
18.5x
13.7x
1.2x
6.7%
0.0%
..
5.7%
--- 
7.1%  /
0.3%
7.7x
10.1x
3.2x
29.2%
88.4%
..
2.8%
27.6% 
12.6%  /
0.2%
14.4x
14.4x
4.7x
32.3%
0.0%
..
2.8%
--- 
-72.7%  /
0.0%
4.2x
2.6x
6.4x
245.2%
445.2%
2025-05-12
12.7%
69.6% 
-100.0%  /
0.0%
3.1x
2.9x
5.2x
166.7%
0.0%
2025-05-12
27.8%
--- 
0.0%  /
0.0%
0.2x
>200x
0x
17.5%
0.0%
..
0.0%
--- 
0.0%  /
0.0%
35.4x
>200x
10x
28.3%
0.0%
..
4.8%
--- 
0.0%  /
0.0%
4.2x
>200x
0.9x
21.8%
0.0%
..
3.3%
--- 
0.0%  /
0.0%
94.5x
42.5x
4.8x
11.3%
-273.2%
..
13.8%
-56.7% 
10.3%  /
-1.7%
8.7x
10.8x
1.1x
13.0%
0.0%
..
5.4%
--- 
19.3%  /
-1.9%
10.6x
11.7x
2.5x
23.5%
0.0%
..
8.1%
--- 
24.6%  /
-2.1%
13.7x
13.9x
2.5x
18.1%
0.0%
..
4.1%
--- 
17.6%  /
-3.0%
25.7x
27.2x
8x
31.3%
0.0%
..
3.0%
--- 
12.7%  /
-3.7%
9.4x
8.9x
1.2x
12.4%
0.0%
..
5.3%
--- 
8.4%  /
-4.5%
8.6x
12.4x
1.4x
16.8%
0.0%
..
4.9%
--- 
4.7%  /
-5.8%
>200x
12.7x
4.6x
27.8%
713.3%
..
2.1%
156.5% 
11.6%  /
-6.1%
>200x
0x
0x
21.1%
0.0%
..
8.8%
--- 
-76.1%  /
-7.4%
15.6x
6.2x
5.6x
108.9%
-166.3%
..
12.2%
-29.5% 
-22.2%  /
-7.8%
6x
7.6x
2.3x
27.3%
15.2%
..
5.4%
6.6% 
-78.2%  /
-12.1%
26.5x
23.5x
7.9x
28.4%
-24.2%
..
1.2%
-3.1% 
-96.5%  /
-20.6%
55.2x
25.8x
6.3x
37.1%
0.0%
..
17.7%
--- 
Trending screeners:
@electric-vehicles
@saas
@cannabis-players
@china
Latin America
India
Dividends
@REITs
@adtech
@airlines
@artificial-intelligence
@auto-parts
@cloud-computing
@crypto
@cybersecurity
@e-commerce
@edtech
@finance-and-technology
@gaming
@internet-of-things
@oil-refining
@real-estate-tech
@renewable-energy
@vaccine-makers

Reviews

2025-05-15
#reports #SYPR

[Sypris Solutions](https://eninvs.com/all.php?name=SYPR) (Auto Parts) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186088)
(2025-05-20, Before Market Open):

- Revenue -16.7% YoY (vs -5.7% in previous quarter and historical rate +12.7%)
- EBITDA margin 3.3% increased compared to -2.8% same period last year
- Net Debt increased by $6 mln over the past reporting period (16.3% of market cap)
- FCF (LTM) -$0 bln (negative), 8.1% of market cap
- EV/EBITDA multiple is 6.1x compared to historical level (75th percentile) of 12.7x
- EV/Sales multiple is 0.4x

2025-05-15
#reports #STE

[STERIS](https://eninvs.com/all.php?name=STE) (Medical equipment supplier) reported for 2025 q1
(2025-05-14, After Market Close):

- Revenue +4.4% YoY (vs -1.8% in previous quarter and historical rate +6.3%)
- EBITDA -1.8% YoY (vs +5.3% in previous quarter and historical rate +26.0%)
- EBITDA margin 28.8% decreased compared to 30.7% same period last year
- Net Debt increased by $35 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 15.7x compared to historical level (75th percentile) of 25.5x
- EV/Sales multiple is 4.1x

2025-05-15
#reports #SEAS

[SeaWorld Entertainment](https://eninvs.com/all.php?name=SEAS) (Theme park owner) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186095)
(2023-11-08, Before Market Open):

- Revenue -3.4% YoY (vs -1.3% in previous quarter and historical rate +2.3%)
- EBITDA -3.3% YoY (vs -7.8% in previous quarter and historical rate +12.4%)
- EBITDA margin 20.6% has not changed compared to 20.5% same period last year
- Net Debt increased by $2.3 bln since the start of the year (82.5% of market cap)
- EV/EBITDA multiple is 8.1x compared to historical level (75th percentile) of 8.9x
- EV/Sales multiple is 2.9x

At the opening of the session the share price went up +1.7%
2025-05-15
#reports #RSKD

[Riskified Ltd.](https://eninvs.com/all.php?name=RSKD) (Software — Application) reported for 2025 q1
(2025-05-14, Before Market Open):

- Revenue +7.9% YoY (vs +11.9% in previous quarter and historical rate +11.9%)
- EBITDA margin -15.9% has not changed compared to -15.8% same period last year
- Net Debt increased by $18 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 11.2% of market cap
- EV/Sales multiple is 1.5x

At the opening of the session the share price went down -6.3% vs S&P500 +0.2%
2025-05-15
#reports #REKR

[Rekor Systems](https://eninvs.com/all.php?name=REKR) (Software — Infrastructure) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185988)
(2025-05-14, After Market Close):

- Revenue -10% YoY (vs +18.2% in previous quarter and historical rate +54.5%)
- EBITDA margin -100.0% increased compared to -120.0% same period last year
- Net Debt decreased by $10 mln over the past reporting period (19.7% of market cap)
- FCF (LTM) +$0 bln (positive), 3.9% of market cap
- EV/Sales multiple is 1.4x

2025-05-15
#reports #PRPO

[Precipio](https://eninvs.com/all.php?name=PRPO) (Diagnostics and Research) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186000)
(2023-11-13, After Market Close):

- Revenue +66.7% YoY (vs +25.0% in previous quarter and historical rate +54.2%)
- Net Debt increased by $1 mln over the past reporting period (0.6% of market cap)
- EV/Sales multiple is 8.5x

At the opening of the session the share price went down -7.1%
2025-05-15
#reports #OPTN

[OptiNose](https://eninvs.com/all.php?name=OPTN) (Drug Manufacturers — Specialty and Generic) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186025)
(2025-03-26, Before Market Open):

- Revenue +120% YoY (vs +10.0% in previous quarter and historical rate +18.3%)
- EBITDA margin -24.2% increased compared to -53.3% same period last year
- Net Debt increased by $28 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$0 bln (positive), 0.3% of market cap
- EV/Sales multiple is 18x

2025-05-15
#reports #NAII

[Natural Alternatives International](https://eninvs.com/all.php?name=NAII) (Packaged Foods) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186083)
(2025-02-18, After Market Close):

- Revenue +16% YoY (vs +36.0% in previous quarter and historical rate +5.0%)
- EBITDA margin -3.4% increased compared to -4.0% same period last year
- Net Debt decreased by $5 mln over the past reporting period (26.1% of market cap)
- FCF (LTM) -$0 bln (negative), 52.3% of market cap
- EV/Sales multiple is 0.5x

At the opening of the session the share price went down -1.0% vs S&P500 +0.1%
2025-05-15
#reports #GWRS

[Global Water Resources](https://eninvs.com/all.php?name=GWRS) (Utilities — Regulated Water) reported for 2025 q1
(2025-05-14, After Market Close):

- Revenue 0% YoY (vs +108.3% in previous quarter and historical rate +16.9%)
- EBITDA +25% YoY (vs -40.0% in previous quarter and historical rate +16.4%)
- EBITDA margin 41.7% increased compared to 33.3% same period last year
- EV/EBITDA multiple is 17.5x compared to historical level (75th percentile) of 20x
- EV/Sales multiple is 5.7x

2025-05-15
#reports #GLBE

[Global-e Online Ltd.](https://eninvs.com/all.php?name=GLBE) (Internet Retail) reported for 2025 q1
(2025-05-14, Before Market Open):

- Revenue +30.1% YoY (vs +42.2% in previous quarter and historical rate +35.6%)
- EBITDA margin -10.0% increased compared to -19.9% same period last year
- Net Debt increased by $29 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.7% of market cap
- EV/Sales multiple is 6.2x

At the opening of the session the share price went down -22.3% vs S&P500 +0.2%
2025-05-15
#reports #EWCZ

[European Wax Center, Inc.](https://eninvs.com/all.php?name=EWCZ) (Household and Personal Products) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185975)
(2025-05-14, Before Market Open):

- Revenue -1.9% YoY (vs -10.7% in previous quarter and historical rate +20.2%)
- EBITDA 0% YoY (vs 0.0% in previous quarter and historical rate +27.5%)
- EBITDA margin 31.4% increased compared to 30.8% same period last year
- Net Debt decreased by $8 mln over the past reporting period (2.5% of market cap)
- FCF (LTM) +$0 bln (positive), 0.9% of market cap
- EV/EBITDA multiple is 9.8x compared to historical level (75th percentile) of 23.7x
- EV/Sales multiple is 3.1x

At the opening of the session the share price went up +15.9% vs S&P500 +0.2%
2025-05-15
#reports #EGAN

[eGain](https://eninvs.com/all.php?name=EGAN) (Software — Application) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185973)
(2025-05-14, After Market Close):

- Revenue -4.5% YoY (vs -8.3% in previous quarter and historical rate +16.2%)
- Net Debt increased by $2 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) -$0 bln (negative), 4.8% of market cap
- EV/EBITDA multiple is 9.9x compared to historical level (75th percentile) of 62x
- EV/Sales multiple is 0.6x

2025-05-15
#reports #DT

[Dynatrace](https://eninvs.com/all.php?name=DT) (Software provider) reported for 2025 q1
(2025-05-14, Before Market Open):

- Revenue +16.8% YoY (vs +19.5% in previous quarter and historical rate +22.3%)
- EBITDA +70.3% YoY (vs +52.5% in previous quarter and historical rate +48.1%)
- EBITDA margin 14.2% increased compared to 9.7% same period last year
- Net Debt decreased by $106 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.2 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 62x compared to historical level (75th percentile) of 100.4x
- EV/Sales multiple is 8.8x

At the opening of the session the share price went up +2.0% vs S&P500 +0.2%
2025-05-15
#reports #DRIO

[DarioHealth](https://eninvs.com/all.php?name=DRIO) (Diagnostics and Research) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185971)
(2025-05-14, Before Market Open):

- Revenue +16.7% YoY (vs +100.0% in previous quarter and historical rate +30.8%)
- EBITDA -44.4% YoY (vs -14.3% in previous quarter and historical rate +69.9%)
- EBITDA margin 142.9% decreased compared to 300.0% same period last year
- Net Debt increased by $14 mln over the past reporting period (92.8% of market cap)
- FCF (LTM) -$0 bln (negative), 39.8% of market cap
- EV/Sales multiple is -0.7x

At the opening of the session the share price went down -7.1% vs S&P500 +0.2%
2025-05-15
#reports #DERM

[Journey Medical Corporation](https://eninvs.com/all.php?name=DERM) (Drug Manufacturers — Specialty and Generic) reported for 2025 q1
(2025-05-14, After Market Close):

- Revenue 0% YoY (vs -6.7% in previous quarter and historical rate -6.0%)
- EBITDA margin -30.8% increased compared to -84.6% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0 bln (negative), 11.4% of market cap
- EV/Sales multiple is 2.2x

2025-05-15
#reports #CDXS

[Codexis](https://eninvs.com/all.php?name=CDXS) (Biotechnology) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185968)
(2025-05-14, After Market Close):

- Revenue -52.9% YoY (vs -22.2% in previous quarter and historical rate -15.8%)
- EBITDA margin -225.0% decreased compared to -52.9% same period last year
- Net Debt increased by $14 mln over the past reporting period (8.7% of market cap)
- EV/Sales multiple is 2.9x

2025-05-15
#reports #CAAS

[China Automotive Systems](https://eninvs.com/all.php?name=CAAS) (Auto Parts) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185967)
(2025-05-14, Before Market Open):

- Revenue +20.1% YoY (vs +18.9% in previous quarter and historical rate +11.1%)
- EBITDA -13.3% YoY (vs -26.3% in previous quarter and historical rate +26.1%)
- EBITDA margin 7.8% decreased compared to 10.8% same period last year
- Net Debt increased by $97 mln over the past reporting period (78.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 50.7% of market cap
- EV/EBITDA multiple is 2.1x compared to historical level (75th percentile) of 2.2x
- EV/Sales multiple is 0.2x

At the opening of the session the share price went up +6.6% vs S&P500 +0.2%
2025-05-15
#reports #AYTU

[Aytu Biopharma](https://eninvs.com/all.php?name=AYTU) (Drug Manufacturers — Specialty and Generic) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186015)
(2023-05-15, After Market Close):

- Revenue 0% YoY (vs -30.4% in previous quarter and historical rate +8.4%)
- EBITDA margin 22.2% increased compared to -5.6% same period last year
- Net Debt increased by $5 mln over the past reporting period (60.4% of market cap)
- FCF (LTM) +$0 bln (positive), 84.6% of market cap
- EV/EBITDA multiple is 15.3x compared to historical level (75th percentile) of 15x
- EV/Sales multiple is 0.2x

At the opening of the session the share price went down -1.1%
2025-05-15
#reports #ABUS

[Arbutus Biopharma Corporation](https://eninvs.com/all.php?name=ABUS) (Biotechnology) reported for 2025 q1
(2025-05-12, Before Market Open):

- Revenue 0% YoY (vs +150.0% in previous quarter and historical rate +13.7%)
- EBITDA margin -1200.0% decreased compared to -900.0% same period last year
- Net Debt increased by $9 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) -$0 bln (negative), 5.0% of market cap
- EV/Sales multiple is 33.6x

At the opening of the session the share price went up +2.2% vs S&P500 +2.6%
2025-05-15
#dividend #GSL

Global Ship Lease will pay dividends in the amount of 0.525 USD per share on 2025-05-22, which is 2.1% of the current price 24.65. Together with previous payments, the annual dividend yield will be 7.6%

(2025-02-21: 0.45 USD)
(2024-11-21: 0.45 USD)
(2024-08-22: 0.45 USD)
2025-05-15
#dividend #PANL

Pangaea Logistics Solutions will pay dividends in the amount of 0.05 USD per share on 2025-05-30, which is 1.2% of the current price 4.33. Together with previous payments, the annual dividend yield will be 8.1%

(2025-02-27: 0.1 USD)
(2024-11-28: 0.1 USD)
(2024-08-29: 0.1 USD)